The First 90 Days: Where Antipsychotics Tip Blood Sugar

Key Takeaways

In an observational study of 96,849 adults with severe mental illness, blood glucose and body weight escalated most rapidly within the first 90 days following the initiation of oral second-generation antipsychotics, with olanzapine driving the steepest trajectories. Among individuals with prediabetes at baseline, the estimated two-year cumulative incidence of type 2 diabetes reached 19.0%, compared with 3.0% in those with normoglycemia at baseline. Glycemic and weight monitoring must be rigorously performed at treatment initiation and at approximately 12 weeks.

The 12 Weeks That Go Unnoticed

Picture a 26-year-old man discharged following his first psychotic episode. The voices in his mind have quieted; his family breathes a collective sigh of relief. He walks out of the hospital with a prescription for olanzapine and an outpatient psychiatric follow-up on the calendar. No one orders a baseline blood glucose panel. Three months later, his jeans feel uncomfortably tight, he contends with relentless hunger, and routine labs drawn for an unrelated issue reveal blood sugars crossing into prediabetes territory. Two years later, he receives a formal diagnosis of type 2 diabetes.

This clinical trajectory is remarkably common, and a major new analysis from the United Kingdom clarifies why. The data reveal that the window in which an antipsychotic inflicts its heaviest metabolic toll is both brief and early: roughly the first three…